Chemed Co. (NYSE:CHE – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 422,500 shares, a drop of 6.3% from the December 31st total of 450,900 shares. Based on an average trading volume of 78,200 shares, the […]
Clinical-stage precision oncology company, Repare Therapeutics Inc., has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial.
EverSource Wealth Advisors LLC reduced its position in Chemed Co. (NYSE:CHE – Free Report) by 4.0% during the third quarter, HoldingsChannel.com reports. The firm owned 481 shares of the company’s stock after selling 20 shares during the period. EverSource Wealth Advisors LLC’s holdings in Chemed were worth $250,000 at the end of the most recent […]
Larson Financial Group LLC purchased a new position in shares of Chemed Co. (NYSE:CHE – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 84 shares of the company’s stock, valued at approximately $44,000. A number of other institutional investors have […]